Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 11.56
+0.31 (2.76%)
Jul 21, 2025, 11:15 AM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 562.61 million as of July 18, 2025. Its market cap has decreased by -27.56% in one year.
Market Cap
562.61M
Enterprise Value
365.10M
Revenue
91.02M
Ranking
n/a
PE Ratio
14.62
Stock Price
11.56
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 562.61M, an increase of 10,666.28%. That is a compound annual growth rate of 21.10%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 120.27B |
| Pro Medicus | 34.26B |
| Cochlear | 20.09B |
| Sonic Healthcare | 13.65B |
| Ramsay Health Care | 8.94B |
| Telix Pharmaceuticals | 8.32B |
| Ansell | 4.42B |
| Mesoblast | 3.08B |